Oliwia Bartkowska
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Oliwia Bartkowska has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Adam Dobosz
Medical University of Warsaw
5 shared publications - Antoni Wojnowski
Medical University of Warsaw
5 shared publications - Emilia Deka
Medical University of Warsaw
5 shared publications - Gabriela Łuczyńska
Medical University of Warsaw
5 shared publications - Hanna Bojanowska
Medical University of Warsaw
5 shared publications - Jan Domińczak
Medical University of Warsaw
5 shared publications
Latest Publications
- Open Access
- 23 May 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 91
Chronic Inflammation and Insulin Resistance as Links between Metabolic Syndrome and Musculoskeletal Disorders
Background: Metabolic syndrome (MetS) affects approximately 25-30% of adults worldwide and is traditionally associated with cardiovascular complications. However, emerging evidence suggests that MetS may also substantially increase the risk of musculoskeletal disorders, including osteoarthritis, sarcopenia, and osteoporosis. Objectives: This review synthesizes current evidence on the molecular and pathophysiological mechanisms connecting MetS to musculoskeletal disorders, with particular focus on chronic inflammation and insulin resistance as central mediators. Methods: A comprehensive literature search was conducted across PubMed and Google Scholar, focusing on publications from 2018-2026. Search terms included metabolic syndrome, chronic inflammation, insulin resistance, musculoskeletal disorders, adipokines, osteoarthritis, and sarcopenia. After reviewing and ranking for relevance, 40 high-impact studies were selected to form the evidence base for this review [40]. Results: The literature reveals that chronic inflammation in MetS, characterized by elevated pro-inflammatory cytokines (IL-6, TNF-α, IL-1β) and dysregulated adipokines (leptin, adiponectin, resistin), creates a systemic inflammatory environment that directly impacts musculoskeletal tissues. Conclusions: Chronic inflammation and insulin resistance represent critical mechanistic links between MetS and musculoskeletal disorders. Interventions targeting inflammation and insulin sensitivity—including lifestyle modifications, omega-3 fatty acids, metabolic drugs (metformin, GLP-1 agonists), intermittent fasting, and inflammasome-targeting approaches—may offer benefits for both metabolic and musculoskeletal health.
- 23 May 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 91
Open AccessChronic Inflammation and Insulin Resistance as Links between Metabolic Syndrome and Musculoskeletal Disorders
Background: Metabolic syndrome (MetS) affects approximately 25-30% of adults worldwide and is traditionally associated with cardiovascular complications. However, emerging evidence suggests that MetS may also substantially increase the risk of musculoskeletal disorders, including osteoarthritis, sarcopenia, and osteoporosis. Objectives: This review synthesizes current evidence on the molecular and pathophysiological mechanisms connecting MetS to musculoskeletal disorders, with particular focus on chronic inflammation and insulin resistance as central mediators. Methods: A comprehensive literature search was conducted across PubMed and Google Scholar, focusing on publications from 2018-2026. Search terms included metabolic syndrome, chronic inflammation, insulin resistance, musculoskeletal disorders, adipokines, osteoarthritis, and sarcopenia. After reviewing and ranking for relevance, 40 high-impact studies were selected to form the evidence base for this review [40]. Results: The literature reveals that chronic inflammation in MetS, characterized by elevated pro-inflammatory cytokines (IL-6, TNF-α, IL-1β) and dysregulated adipokines (leptin, adiponectin, resistin), creates a systemic inflammatory environment that directly impacts musculoskeletal tissues. Conclusions: Chronic inflammation and insulin resistance represent critical mechanistic links between MetS and musculoskeletal disorders. Interventions targeting inflammation and insulin sensitivity—including lifestyle modifications, omega-3 fatty acids, metabolic drugs (metformin, GLP-1 agonists), intermittent fasting, and inflammasome-targeting approaches—may offer benefits for both metabolic and musculoskeletal health.
- Open Access
- 15 May 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 91, 70664
Orthorexia Nervosa and Muscle Dysmorphia as Emerging Mental Health Threats in Athletes: A Comprehensive Narrative Review
Background: In modern sports, the line between healthy dedication and unhealthy obsession is becoming increasingly blurred. While classic eating disorders like anorexia and bulimia are well-known, Orthorexia Nervosa (ON) and Muscle Dysmorphia (MD) are growing problems that affect athletes of all genders but often go unnoticed. Objective: This review summarizes current knowledge regarding the prevalence, causes, and health consequences of ON and MD in athletes, based on literature acquired from PubMed, Embase, and Web of Science. Results: Evidence clearly shows that athletes are at a much higher risk for both conditions compared to the general population. Because strict diets and constant body monitoring are considered "normal" in sports, these disorders are often difficult to spot. Key risk factors include perfectionistic personality traits, pressure to meet weight requirements in certain sports, and the influence of social media, which promotes unrealistic body standards. Conclusion: Both ON and MD can lead to serious physical health issues, such as Relative Energy Deficiency in Sport (RED-S). Current findings highlight an urgent need for better screening tools designed specifically for athletes. Furthermore, a significant change in how we educate athletes and coaches about mental health and nutrition is necessary.
- 15 May 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 91, 70664
Open AccessOrthorexia Nervosa and Muscle Dysmorphia as Emerging Mental Health Threats in Athletes: A Comprehensive Narrative Review
Background: In modern sports, the line between healthy dedication and unhealthy obsession is becoming increasingly blurred. While classic eating disorders like anorexia and bulimia are well-known, Orthorexia Nervosa (ON) and Muscle Dysmorphia (MD) are growing problems that affect athletes of all genders but often go unnoticed. Objective: This review summarizes current knowledge regarding the prevalence, causes, and health consequences of ON and MD in athletes, based on literature acquired from PubMed, Embase, and Web of Science. Results: Evidence clearly shows that athletes are at a much higher risk for both conditions compared to the general population. Because strict diets and constant body monitoring are considered "normal" in sports, these disorders are often difficult to spot. Key risk factors include perfectionistic personality traits, pressure to meet weight requirements in certain sports, and the influence of social media, which promotes unrealistic body standards. Conclusion: Both ON and MD can lead to serious physical health issues, such as Relative Energy Deficiency in Sport (RED-S). Current findings highlight an urgent need for better screening tools designed specifically for athletes. Furthermore, a significant change in how we educate athletes and coaches about mental health and nutrition is necessary.
- Open Access
- 14 May 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 91, 70713
Guanfacine Extended Release in the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: A Narrative Review
Attention-deficit/hyperactivity disorder (ADHD) is a prevalent neurodevelopmental disorder in children and adolescents and is associated with substantial functional impairment. Although psychostimulants are considered first-line pharmacotherapy, a significant proportion of patients experience inadequate response, poor tolerability, or contraindications to stimulant use. Consequently, non-stimulant medications remain an important component of ADHD management. Guanfacine extended release (GXR), a selective α2A-adrenergic receptor agonist, is approved for the treatment of pediatric ADHD and represents a well-established non-stimulant option. Evidence derived from randomized controlled trials, meta-analyses, and systematic reviews indicates that GXR is effective as monotherapy and as adjunctive therapy to psychostimulants in children and adolescents aged 6–17 years. Across studies, GXR demonstrates clinically meaningful reductions in core ADHD symptoms compared with placebo, with reported effect sizes generally ranging from 0.5 to 0.8. The most commonly reported adverse events are sedation-related symptoms, including somnolence and fatigue, which are typically mild to moderate and tend to decrease with ongoing treatment. Cardiovascular effects are usually modest and consist mainly of small reductions in blood pressure and heart rate, with clinically significant events occurring infrequently. Overall, available data indicate that guanfacine extended release is an effective and generally well-tolerated non-stimulant treatment for ADHD in pediatric and adolescent populations. Its clinical utility is particularly relevant in patients with insufficient response or intolerance to stimulants, as well as in those requiring adjunctive pharmacotherapy. Further studies are warranted to evaluate long-term outcomes and to better define its comparative effectiveness in specific clinical subgroups.
- 14 May 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 91, 70713
Open AccessGuanfacine Extended Release in the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: A Narrative Review
Attention-deficit/hyperactivity disorder (ADHD) is a prevalent neurodevelopmental disorder in children and adolescents and is associated with substantial functional impairment. Although psychostimulants are considered first-line pharmacotherapy, a significant proportion of patients experience inadequate response, poor tolerability, or contraindications to stimulant use. Consequently, non-stimulant medications remain an important component of ADHD management. Guanfacine extended release (GXR), a selective α2A-adrenergic receptor agonist, is approved for the treatment of pediatric ADHD and represents a well-established non-stimulant option. Evidence derived from randomized controlled trials, meta-analyses, and systematic reviews indicates that GXR is effective as monotherapy and as adjunctive therapy to psychostimulants in children and adolescents aged 6–17 years. Across studies, GXR demonstrates clinically meaningful reductions in core ADHD symptoms compared with placebo, with reported effect sizes generally ranging from 0.5 to 0.8. The most commonly reported adverse events are sedation-related symptoms, including somnolence and fatigue, which are typically mild to moderate and tend to decrease with ongoing treatment. Cardiovascular effects are usually modest and consist mainly of small reductions in blood pressure and heart rate, with clinically significant events occurring infrequently. Overall, available data indicate that guanfacine extended release is an effective and generally well-tolerated non-stimulant treatment for ADHD in pediatric and adolescent populations. Its clinical utility is particularly relevant in patients with insufficient response or intolerance to stimulants, as well as in those requiring adjunctive pharmacotherapy. Further studies are warranted to evaluate long-term outcomes and to better define its comparative effectiveness in specific clinical subgroups.
- Open Access
- 7 April 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 89
The use of platelet-rich plasma injections in the treatment of knee osteoarthritis - review of the literature
Introduction: Knee osteoarthritis (KOA) is one of the most common degenerative joint diseases, affecting millions of people worldwide. It is characterized by progressive cartilage degradation, chronic pain, joint stiffness, and functional impairment. Traditional treatment methods, including pharmacotherapy and intra-articular injections of corticosteroids or hyaluronic acid, provide limited and often short-term relief. Platelet-rich plasma (PRP) has emerged as a promising regenerative therapy due to its high concentration of growth factors that may stimulate tissue healing and reduce inflammation. Objective: The aim of this study is to review the latest literature on the use of platelet-rich plasma injections in patients with knee osteoarthritis. Material and methods: A literature review was conducted on databases such as PubMed, Google Scholar, and SciSpace using the terms: "knee osteoarthritis", "platelet-rich plasma", "PRP injections", "intra-articular injections", "knee OA treatment". Conclusions: Knee osteoarthritis is a highly prevalent condition that significantly impacts quality of life. Platelet-rich plasma has demonstrated positive effects on pain reduction and functional improvement in patients with KOA. PRP injections lead to superior outcomes compared to placebo and hyaluronic acid, with therapeutic effects lasting 12-24 months. However, there is lack of standardization in PRP preparation protocols, and further studies are necessary to establish optimal treatment parameters.
- 7 April 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 89
Open AccessThe use of platelet-rich plasma injections in the treatment of knee osteoarthritis - review of the literature
Introduction: Knee osteoarthritis (KOA) is one of the most common degenerative joint diseases, affecting millions of people worldwide. It is characterized by progressive cartilage degradation, chronic pain, joint stiffness, and functional impairment. Traditional treatment methods, including pharmacotherapy and intra-articular injections of corticosteroids or hyaluronic acid, provide limited and often short-term relief. Platelet-rich plasma (PRP) has emerged as a promising regenerative therapy due to its high concentration of growth factors that may stimulate tissue healing and reduce inflammation. Objective: The aim of this study is to review the latest literature on the use of platelet-rich plasma injections in patients with knee osteoarthritis. Material and methods: A literature review was conducted on databases such as PubMed, Google Scholar, and SciSpace using the terms: "knee osteoarthritis", "platelet-rich plasma", "PRP injections", "intra-articular injections", "knee OA treatment". Conclusions: Knee osteoarthritis is a highly prevalent condition that significantly impacts quality of life. Platelet-rich plasma has demonstrated positive effects on pain reduction and functional improvement in patients with KOA. PRP injections lead to superior outcomes compared to placebo and hyaluronic acid, with therapeutic effects lasting 12-24 months. However, there is lack of standardization in PRP preparation protocols, and further studies are necessary to establish optimal treatment parameters.
- Open Access
- 28 March 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 89
Sleep as an ‘Ergogenic Supplement’: The Role of Sleep Quality, Duration and Patterns in Preventing Sports Injuries - A Systematic Review
BACKGROUND: Sleep is recognized as a key factor influencing athletic performance and injury prevention. Despite growing interest in sleep as a modifiable risk factor, the relationship between sleep parameters and the risk of sports injuries requires systematic evaluation. AIM: This study focuses on presenting the relationship between the duration, quality and patterns of sleep and the occurrence and prevention of sports injuries based on current knowledge. MATERIAL AND METHODS: This systematic review was conducted using multiple databases, including ScienceDirect, PubMed and Google Scholar. After removing duplicates, 165 unique articles compatible with the study topic were identified. The 31 most relevant articles were selected and used to analyse the association between sleep parameters and the effects of sports injuries in athlete populations. RESULTS: Strong evidence has been identified linking insufficient sleep to an increased risk of sports injuries in many groups of athletes. In addition, the study confirmed that poor sleep quality was associated with a significantly higher likelihood of injury. The study confirmed mechanisms connecting sleep and injury include impaired cognitive function, slowed reaction time, weakened neuromuscular control, increased inflammation and impaired tissue regeneration. CONCLUSIONS: Evidence shows that sleep has a protective effect against injuries when it is sufficiently long and of adequate quality. Healthcare professionals, coaches and athletes should prioritise sleep hygiene measures as part of comprehensive injury prevention strategies.
- 28 March 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 89
Open AccessSleep as an ‘Ergogenic Supplement’: The Role of Sleep Quality, Duration and Patterns in Preventing Sports Injuries - A Systematic Review
BACKGROUND: Sleep is recognized as a key factor influencing athletic performance and injury prevention. Despite growing interest in sleep as a modifiable risk factor, the relationship between sleep parameters and the risk of sports injuries requires systematic evaluation. AIM: This study focuses on presenting the relationship between the duration, quality and patterns of sleep and the occurrence and prevention of sports injuries based on current knowledge. MATERIAL AND METHODS: This systematic review was conducted using multiple databases, including ScienceDirect, PubMed and Google Scholar. After removing duplicates, 165 unique articles compatible with the study topic were identified. The 31 most relevant articles were selected and used to analyse the association between sleep parameters and the effects of sports injuries in athlete populations. RESULTS: Strong evidence has been identified linking insufficient sleep to an increased risk of sports injuries in many groups of athletes. In addition, the study confirmed that poor sleep quality was associated with a significantly higher likelihood of injury. The study confirmed mechanisms connecting sleep and injury include impaired cognitive function, slowed reaction time, weakened neuromuscular control, increased inflammation and impaired tissue regeneration. CONCLUSIONS: Evidence shows that sleep has a protective effect against injuries when it is sufficiently long and of adequate quality. Healthcare professionals, coaches and athletes should prioritise sleep hygiene measures as part of comprehensive injury prevention strategies.